-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Skye Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
- Skye Bioscience, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.97M, a 79.9% increase year-over-year.
- Skye Bioscience, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$23.6M, a 40.9% increase year-over-year.
- Skye Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$34.7M, a 89.7% decline from 2022.
- Skye Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$18.3M, a 133% decline from 2021.
- Skye Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$7.85M, a 24.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)